VHL antibody
Product Specifications
Background
Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as a target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2.
Synonyms
Von Hippel-Lindau disease tumor suppressor|Protein G7|pVHL|VHL
Gene ID
7428
UniProt
P40337
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
Von Hippel-Lindau tumor suppressor
Target
VHL
Clonality
Polyclonal
Isotype
IgG
Applications
ELISA, WB, IHC, IF
Field of Research
Cancer, Metabolism
Purification
Immunogen affinity purified
Dilution
WB: 1:500-1:2000; IHC: 1:50-1:200; IF: 1:20-1:200
Purity
≥95% as determined by SDS-PAGE
Form
Liquid
Molecular Weight
18-24 kDa
Storage Conditions
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
Tested Applications
ELISA, WB, IHC, IF
Immunogen Sequence
107-213
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
039729-ML750 100 µL
PCDHA10, CT (PCDHA10, CNRS8, Protocadherin alpha-10) (MaxLight 750) discontinued
Ask
View Details 
